BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 30978666)

  • 1. Innate sensors that regulate vaccine responses.
    Georg P; Sander LE
    Curr Opin Immunol; 2019 Aug; 59():31-41. PubMed ID: 30978666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Pattern Recognition Receptors (PRR) for Vaccine Adjuvantation: From Synthetic PRR Agonists to the Potential of Defective Interfering Particles of Viruses.
    Vasou A; Sultanoglu N; Goodbourn S; Randall RE; Kostrikis LG
    Viruses; 2017 Jul; 9(7):. PubMed ID: 28703784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trained Immunity-Based Vaccines: A New Paradigm for the Development of Broad-Spectrum Anti-infectious Formulations.
    Sánchez-Ramón S; Conejero L; Netea MG; Sancho D; Palomares Ó; Subiza JL
    Front Immunol; 2018; 9():2936. PubMed ID: 30619296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vaccination--new facts from basic research].
    Dalpke AH
    MMW Fortschr Med; 2010 Jul; 152 Suppl 2():42-6. PubMed ID: 21591318
    [No Abstract]   [Full Text] [Related]  

  • 5. Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants.
    Olive C
    Expert Rev Vaccines; 2012 Feb; 11(2):237-56. PubMed ID: 22309671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate receptors for adaptive immunity.
    Michallet MC; Rota G; Maslowski K; Guarda G
    Curr Opin Microbiol; 2013 Jun; 16(3):296-302. PubMed ID: 23659869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine adjuvants: putting innate immunity to work.
    Coffman RL; Sher A; Seder RA
    Immunity; 2010 Oct; 33(4):492-503. PubMed ID: 21029960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity.
    Kowalczyk A; Doener F; Zanzinger K; Noth J; Baumhof P; Fotin-Mleczek M; Heidenreich R
    Vaccine; 2016 Jul; 34(33):3882-93. PubMed ID: 27269061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in adjuvant development for vaccines: DAMPs and PAMPs as potential new adjuvants.
    Miyaji EN; Carvalho E; Oliveira ML; Raw I; Ho PL
    Braz J Med Biol Res; 2011 Jun; 44(6):500-13. PubMed ID: 21584443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Principles of Vaccination.
    Zepp F
    Methods Mol Biol; 2016; 1403():57-84. PubMed ID: 27076125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modes of Action for Mucosal Vaccine Adjuvants.
    Aoshi T
    Viral Immunol; 2017; 30(6):463-470. PubMed ID: 28436755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine Adjuvants.
    Kumar S; Sunagar R; Gosselin E
    Front Immunol; 2019; 10():1144. PubMed ID: 31191528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbohydrates as putative pattern recognition receptor agonists in vaccine development.
    Mu R; Dong L; Wang C
    Trends Immunol; 2023 Oct; 44(10):845-857. PubMed ID: 37684173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate endogenous adjuvants prime to desirable immune responses via mucosal routes.
    Wang X; Meng D
    Protein Cell; 2015 Mar; 6(3):170-84. PubMed ID: 25503634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants.
    Ong GH; Lian BSX; Kawasaki T; Kawai T
    Front Cell Infect Microbiol; 2021; 11():745016. PubMed ID: 34692565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond adjuvants: Antagonizing inflammation to enhance vaccine immunity.
    Alter G; Sekaly RP
    Vaccine; 2015 Jun; 33 Suppl 2():B55-9. PubMed ID: 26022570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting early events in T cell activation to construct improved vaccines.
    Buchan GS; Young SL; Lockhart EA; Wales J; Faulkner L; Slobbe L; Baird MA
    Mol Immunol; 2000 Jun; 37(9):545-52. PubMed ID: 11163404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Guide to IL-1 family cytokines in adjuvanticity.
    Muñoz-Wolf N; Lavelle EC
    FEBS J; 2018 Jul; 285(13):2377-2401. PubMed ID: 29656546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies to link innate and adaptive immunity when designing vaccine adjuvants.
    Garlapati S; Facci M; Polewicz M; Strom S; Babiuk LA; Mutwiri G; Hancock RE; Elliott MR; Gerdts V
    Vet Immunol Immunopathol; 2009 Mar; 128(1-3):184-91. PubMed ID: 19042032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring the Adjuvant Activity of RNA Vaccines.
    Pardi N; Weissman D
    Methods Mol Biol; 2017; 1499():143-153. PubMed ID: 27987147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.